Metabolic impact of empagliflozin in patients with acute decompensated heart failure:A secondary analysis of the EMPAG-HF trial

20 May 2023 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Acute heart failure - pharmacotherapy Pharmacotherapy HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by